Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis

Oral Diseases

Volumn 20, Issue 2, 2014, Pages 171-177

  Prakasam, S ^a   Srinivasan, M ^a  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Biological markers; CD14 antigen; Chronic periodontitis; Dental scaling; Diagnosis; Root planing; Saliva; Toll like receptors

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; TOLL LIKE RECEPTOR 2;

ADULT; CHEMISTRY; CHRONIC PERIODONTITIS; EVALUATION STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; SALIVA;

ADULT; BIOLOGICAL MARKERS; CHRONIC PERIODONTITIS; CYTOKINES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SALIVA; TOLL-LIKE RECEPTOR 2;

EID: 84893815456     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12085     Document Type: Article

References (47)

1. Albandar JM (2002). Periodontal diseases in North America. Periodontol 2000 29: 31-69.
2. Al-Sabbagh M, Alladah A, Lin Y et al (2012). Bone remodeling-associated salivary biomarker MIP-1alpha distinguishes periodontal disease from health. J Periodontal Res 47: 389-395.
3. Ambatipudi KS, Lu B, Hagen FK, Melvin JE, Yates JR III (2009). Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J Proteome Res 8: 5093.
4. Armitage GC (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4: 1-6.
5. Armitage GC (2004). Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 34: 9-21.
6. Azevedo LR, Damante JH, Lara VS, Lauris JRP (2005). Age-related changes in human sublingual glands: a post mortem study. Arch Oral Biol 50: 565-574.
7. Beklen A, Hukkanen M, Richardson R, Konttinen YT (2008). Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 23: 425-431.
8. Bonassi S, Neri M, Puntoni R (2001). Validation of biomarkers as early predictors of disease. Mutat Res 480-481: 349-358.
9. Borra RC, de Mesquita Barros F, de Andrade Lotufo M, Villanova FE, Andrade PM (2009). Toll-like receptor activity in recurrent aphthous ulceration. J Oral Pathol Med 38: 289-298.
10. Buduneli N, Ozcaka O, Nalbantsoy A (2011). Salivary and plasma levels of toll-like receptor 2 and toll-like receptor 4 in chronic periodontitis. J Periodontol 82: 878-884.
11. Burns E, Bachrach G, Shapira L, Nussbaum G (2006). Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 177: 8296-8300.
12. Costa PP, Trevisan GL, Macedo GO et al (2010). Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol 81: 384-391.
13. Fischer D, Ship JA (1999). Effect of age on variability of parotid salivary gland flow rates over time. Age Ageing 28: 557-561.
14. Fleissig Y, Reichenberg E, Redlich M et al (2010). Comparative proteomic analysis of human oral fluids according to gender and age. Oral Dis 16: 831-838.
15. Giannobile WV (1997). Crevicular fluid biomarkers of oral bone loss. Curr Opin Periodontol 4: 11-20.
16. Hajishengallis G (2010). Too old to fight? Aging and its toll on innate immunity. Mol Oral Microbiol 25: 25-37.
17. Hajishengallis G, Martin M, Schifferle RE, Genco RJ (2002). Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors. Infect Immun 70: 6658-6664.
18. Hajishengallis G, Tapping RI, Harokopakis E et al (2006). Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol 8: 1557-1570.
19. Isaza-Guzman DM, Aristizabal-Cardona D, Martinez-Pabon MC, Velasquez-Echeverri H, Tobon-Arroyave SI (2008). Estimation of sCD14 levels in saliva obtained from patients with various periodontal conditions. Oral Dis 14: 450-456.
20. Jin L, Darveau RP (2001). Soluble CD14 levels in gingival crevicular fluid of subjects with untreated adult periodontitis. J Periodontol 72: 634-640.
21. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ (2007). Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol 22: 145-151.
22. Kinney JS, Ramseier CA, Giannobile WV (2007). Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 1098: 230-251.
23. Kitchens RL (2000). Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol 74: 61-82.
24. Kornman KS (2008). Mapping the pathogenesis of periodontitis: a new look. J Periodontol 79: 1560-1568.
25. Kuroishi T, Tanaka Y, Sakai A, Sugawara Y, Komine K, Sugawara S (2007). Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol 44: 1969-1976.
26. Lappin DF, Sherrabeh S, Erridge C (2011). Stimulants of Toll-like receptors 2 and 4 are elevated in saliva of periodontitis patients compared with healthy subjects. J Clin Periodontol 38: 318-325.
27. LeBouder E, Rey-Nores JE, Rushmere NK et al (2003). Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 171: 6680-6689.
28. Moreira CR, Azevedo LR, Lauris JRP, Taga R, Damante JH (2006). Quantitative age-related differences in human sublingual gland. Arch Oral Biol 51: 960-966.
29. Nagler RM (2004). Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology 5: 223-233.
30. Nakata T, Yasuda M, Fujita M et al (2006). CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell Microbiol 8: 1899-1909.
31. Offenbacher S, Barros SP, Beck JD (2008). Rethinking periodontal inflammation. J Periodontol 79: 1577-1584.
32. Ozcaka O, Nalbantsoy A, Buduneli N (2011). Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodontal Res 46: 592-598.
33. Ozinsky A, Underhill DM, Fontenot JD et al (2000). The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97: 13766-13771.
34. Pasare C, Medzhitov R (2005). Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560: 11-18.
35. Ramseier CA, Kinney JS, Herr AE et al (2009). Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 80: 436-446.
36. Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F (2005). The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 44: 77-82.
37. Rosa N, Correia MJ, Arrais JP et al (2012). From the salivary proteome to the OralOme: comprehensive molecular oral biology. Arch Oral Biol 57: 853-864.
38. Ryan ME (2005). Nonsurgical approaches for the treatment of periodontal diseases. Dent Clin North Am 49: 611-636, vii.
39. Sexton WM, Lin Y, Kryscio RJ, Dawson DR, 3rd Ebersole JL, Miller CS (2011). Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 38: 434-441.
40. Srinivasan M, Kodumudi KN, Zunt SL (2008). Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin Immunol 126: 31-37.
41. Taba M Jr, Kinney J, Kim AS, Giannobile WV (2005). Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am 49: 551-571, vi.
42. Teles RP, Likhari V, Socransky SS, Haffajee AD (2009). Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res 44: 411-417.
43. Tylenda CA, Ship JA, Fox PC, Baum BJ (1988). Evaluation of submandibular salivary flow rate in different age groups. J Dent Res 67: 1225-1228.
44. Uehara A, Sugawara S, Watanabe K et al (2003). Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clin Diagn Lab Immunol 10: 286-292.
45. Uehara A, Fujimoto Y, Fukase K, Takada H (2007). Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 44: 3100-3111.
46. Underhill DM (2003). Toll-like receptors: networking for success. Eur J Immunol 33: 1767-1775.
47. Zunt SL, Burton LV, Goldblatt LI, Dobbins EE, Srinivasan M (2009). Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells. Clin Exp Immunol 156: 285-293.